2Hunter DL, Lassiter TL, Padilla S. Gestational exposure to chlorpyrifos: comparative distribution of trichloropyridinol in the fetus and dam[ J]. Toxicol Appl Pharmacol, 1999,158( 1 ) : 16.
3Moser VC, Padilla S. Age- and gender- related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats [ J ]. Toxicol Appl Pharmacol, 1998,149 ( 1 ) :107.
4Atterberry "IT, Burnett WT, Chambers JE. Age - related differences in parathion and chlorpyrifos toxicity in male rats: target and nontarget esterase sensitivity and cytochrome P450 - mediated metabolism[J]. Toxicol Appl Pharmacol,1997,147(2) :411.
5Sighart W. Structure and pharmacology of γ - aminobutyie acida subtypes[J]. Pharmacol Rew, 1995,47(2) :182.
6Johnson MK. Symposium introduction: retrospect and prospects for neuropathy target esterase ( NTE ) and the delayed polyneuropathy (OPCDP) induced by some organophoros esterase[ J]. Chem- Biol Interactions, 1993,87 ( 2 ) :339.
7ECETOC. Organophesphrous pesticides and long - term effects on the nervous system[ M]. Brussesl, 1998.11 - 17.
8Abou - Donia MB. Involvement of cytoskeletal proteins in the mechanisms of organophosphoros ester - induced delayed neurotoxicity[J]. Clin Exp Pharmacal, 1995,22(2) :358.
9De Bleecker J,Vanden Neucker K, Colardyn F. Intermediate syndrome in organophosphorus poisoning:a prospective study[ J ]. Crit Care Med, 1993,21 (6) : 1706.
